BioMinerva Group

Synergy, key to your success!

BioMinerva Group specializes in strategic alliance and business development consultancy in the fields of research reagents and therapeutics.

ABOUT BIOMINERVA GROUP
Dr. Jing Xu is the president and founder of BioMinerva Group. Dr. Xu has more than fourteen years of experience in business development and corporate partnering in biotech and pharmaceutical industry.  Earlier in her career, she had more than a decade of experience in life science research prior to transitioning to corporate management.  Dr. Xu received her doctoral degree in Molecular Biophysics and Biochemistry from Yale University and conducted her postdoctoral research at the Scripps Research Institute.

Selected Conferences:

Global Strategic Alliances and Corporate Development:
2004
SRI's Inaugural BioAsia-Pacific Licensing & Deal-making Summit
Originator, co-Organizer and Conference co-Chair

Nucleic Acid-based Therapeutics:
2004
SRI's 2nd Annual Nucleic Acid World Summit
Originator, co-Organizer and Conference Chair

SRI's 2nd Annual siRNA in Drug Discovery & Development
Originator, co-Organizer and Conference Chair

2003
SRI's Nucleic Acid World Summit
Originator, co-Organizer and Conference Chair

SRI's 1st International siRNA in Drug Discovery & Development
Originator, Organizer and Confernce co-Chair

Functional Genomics, Proteomics and Genomics:
2003
SRI's Biochips: From Novel Technology to Latest Applications
Advisor, co-Organizer and Conference co-Chair

Selected Publications:

Hands across the ocean.
Jing Xu, BioMinerva Group. Current Drug Discovery. September 2004

Current and emerging therapies for type 2 diabetes.
Jing Xu, BioMinerva Group. IDrugs. 2004 Mar;7(3):249-56.

Small RNA, big quest.
Jing Xu, BioMinerva Group. Current Drug Discovery,June 2003

Determining RNA solution structure by segmental isotopic labeling and NMR: application to Caenorhabditis elegans spliced leader RNA 1.
Xu J, Lapham J, Crothers DM.(1996)Proc Natl Acad Sci U S A. 93(1):44-8.